PT885014E - Composicoes farmaceuticas contendo polimeros orto ester tamponados - Google Patents
Composicoes farmaceuticas contendo polimeros orto ester tamponadosInfo
- Publication number
- PT885014E PT885014E PT97906128T PT97906128T PT885014E PT 885014 E PT885014 E PT 885014E PT 97906128 T PT97906128 T PT 97906128T PT 97906128 T PT97906128 T PT 97906128T PT 885014 E PT885014 E PT 885014E
- Authority
- PT
- Portugal
- Prior art keywords
- tamponados
- pharmaceutical compositions
- compositions containing
- containing polymers
- orto
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96103391 | 1996-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT885014E true PT885014E (pt) | 2003-02-28 |
Family
ID=8222532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97906128T PT885014E (pt) | 1996-03-05 | 1997-02-26 | Composicoes farmaceuticas contendo polimeros orto ester tamponados |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6440460B1 (pt) |
| EP (1) | EP0885014B1 (pt) |
| JP (1) | JP4225570B2 (pt) |
| KR (1) | KR100441821B1 (pt) |
| AT (1) | ATE226450T1 (pt) |
| AU (1) | AU722303C (pt) |
| DE (1) | DE69716586T2 (pt) |
| DK (1) | DK0885014T3 (pt) |
| ES (1) | ES2185911T3 (pt) |
| PT (1) | PT885014E (pt) |
| WO (1) | WO1997032606A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020099438A1 (en) * | 1998-04-15 | 2002-07-25 | Furst Joseph G. | Irradiated stent coating |
| US20030040790A1 (en) | 1998-04-15 | 2003-02-27 | Furst Joseph G. | Stent coating |
| US8070796B2 (en) | 1998-07-27 | 2011-12-06 | Icon Interventional Systems, Inc. | Thrombosis inhibiting graft |
| US7967855B2 (en) | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
| US7168489B2 (en) * | 2001-06-11 | 2007-01-30 | Halliburton Energy Services, Inc. | Orthoester compositions and methods for reducing the viscosified treatment fluids |
| US8016881B2 (en) | 2002-07-31 | 2011-09-13 | Icon Interventional Systems, Inc. | Sutures and surgical staples for anastamoses, wound closures, and surgical closures |
| ES2315526T3 (es) | 2002-09-09 | 2009-04-01 | Nektar Therapeutics Al, Corporation | Metodo para preparar derivados polimericos solubles en agua que llevan un acido carboxilico terminal. |
| US7691381B2 (en) * | 2004-04-15 | 2010-04-06 | Allergan, Inc. | Stabilized biodegradable neurotoxin implants |
| US20060200048A1 (en) * | 2005-03-03 | 2006-09-07 | Icon Medical Corp. | Removable sheath for device protection |
| WO2006110197A2 (en) | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
| US7540995B2 (en) | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
| US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
| BRPI0718696A2 (pt) * | 2006-11-09 | 2013-12-31 | Alcon Res Ltd | Matriz de polímero insolúvel em água para liberação de fármaco. |
| US20080114076A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Punctal plug comprising a water-insoluble polymeric matrix |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| US8398916B2 (en) | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
| BR112016030273A8 (pt) | 2014-06-24 | 2021-05-18 | Icon Medical Corp | dispositivo médico e método para formar o referido dispositivo |
| WO2017151548A1 (en) | 2016-03-04 | 2017-09-08 | Mirus Llc | Stent device for spinal fusion |
| PE20211202A1 (es) | 2017-08-24 | 2021-07-05 | Novo Nordisk As | Composiciones de glp-1 y sus usos |
| PE20221575A1 (es) | 2020-02-18 | 2022-10-06 | Novo Nordisk As | Formulaciones farmaceuticas |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
| US4010196A (en) * | 1975-06-25 | 1977-03-01 | American Home Products Corporation | Linear polyester salts |
| US4268643A (en) * | 1979-10-25 | 1981-05-19 | Societa Italiana Resine S.I.R. S.P.A. | Process for improving the stability of acetal polymers |
| US4346709A (en) * | 1980-11-10 | 1982-08-31 | Alza Corporation | Drug delivery devices comprising erodible polymer and erosion rate modifier |
| EP0052916B1 (en) * | 1980-11-10 | 1985-01-02 | Alza Corporation | Erodible polymer containing erosion rate modifier |
| DE3642662A1 (de) * | 1986-10-02 | 1988-04-14 | Hoechst Ag | Parenterale depotzubereitungen von regulatorischen peptiden enthaltend calciumacetat-glycerin-addukt, verfahren zu ihrer herstellung sowie die verwendung des addukts |
| US5030457A (en) | 1989-08-28 | 1991-07-09 | Pharmaceutical Delivery Systems, Inc. | Bioerodible polymers useful for the controlled release of therapeutic agents |
| KR920702383A (ko) | 1989-08-28 | 1992-09-03 | 원본미기재 | 치료제의 방출을 조절하는데 유용한 생부식성 중합체 |
| AU2261592A (en) | 1991-06-20 | 1993-01-25 | Pharmaceutical Delivery Systems, Inc. | Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions |
| US5700485A (en) * | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
-
1997
- 1997-02-26 KR KR10-1998-0706905A patent/KR100441821B1/ko not_active IP Right Cessation
- 1997-02-26 EP EP97906128A patent/EP0885014B1/en not_active Expired - Lifetime
- 1997-02-26 AU AU20934/97A patent/AU722303C/en not_active Ceased
- 1997-02-26 US US09/117,359 patent/US6440460B1/en not_active Expired - Fee Related
- 1997-02-26 ES ES97906128T patent/ES2185911T3/es not_active Expired - Lifetime
- 1997-02-26 DE DE69716586T patent/DE69716586T2/de not_active Expired - Fee Related
- 1997-02-26 JP JP53141397A patent/JP4225570B2/ja not_active Expired - Fee Related
- 1997-02-26 WO PCT/EP1997/000906 patent/WO1997032606A1/en active IP Right Grant
- 1997-02-26 AT AT97906128T patent/ATE226450T1/de not_active IP Right Cessation
- 1997-02-26 DK DK97906128T patent/DK0885014T3/da active
- 1997-02-26 PT PT97906128T patent/PT885014E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000506148A (ja) | 2000-05-23 |
| ATE226450T1 (de) | 2002-11-15 |
| AU2093497A (en) | 1997-09-22 |
| DE69716586T2 (de) | 2003-07-17 |
| AU722303C (en) | 2001-12-06 |
| KR19990087477A (ko) | 1999-12-27 |
| ES2185911T3 (es) | 2003-05-01 |
| AU722303B2 (en) | 2000-07-27 |
| WO1997032606A1 (en) | 1997-09-12 |
| KR100441821B1 (ko) | 2004-10-15 |
| DE69716586D1 (de) | 2002-11-28 |
| EP0885014A1 (en) | 1998-12-23 |
| EP0885014B1 (en) | 2002-10-23 |
| DK0885014T3 (da) | 2003-02-24 |
| US6440460B1 (en) | 2002-08-27 |
| JP4225570B2 (ja) | 2009-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT885014E (pt) | Composicoes farmaceuticas contendo polimeros orto ester tamponados | |
| DK0874642T3 (da) | Lægemiddelformuleringer med forhalet frigørelse | |
| MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
| DE69434258D1 (de) | Mikroverkapselte 1,2-benzazole | |
| HK1041011A1 (en) | Cross-linked hyaluronic acids and medical uses thereof | |
| WO1999007351A3 (en) | Indole derivatives and their use as mcp-1 antagonists | |
| IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| EP0815853A3 (en) | Sustained-release preparation for bioactive substance having an acidic group | |
| DE69727956D1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| NO20000284D0 (no) | Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen | |
| DE69725860D1 (de) | PLAN ZUR VERABREICHUNG VON H+, K+-ATPase INHIBITOREN | |
| BG106927A (en) | Matrix tablet for prolonged release of trimetazidine after oral administration | |
| MY129437A (en) | Drug formulation having controlled release of active compound | |
| IS1985B (is) | Lyfjafræðilegar örkúlur með valprósýru til inngjafar um munn | |
| HK1043945A1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine. | |
| BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
| MX9602951A (es) | Composiciones de metronidazol de liberacion modificada y metodos para fabricar y utilizar las mismas. | |
| MX9806229A (es) | Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas. | |
| ATE203665T1 (de) | Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung | |
| PT1180094E (pt) | Aminoacidos policiclicos fundidos como agentes farmaceuticos | |
| PT1017681E (pt) | Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios | |
| SE9902742D0 (sv) | New pharmaceutical formultion | |
| CA2243988A1 (en) | Pharmaceutical compositions containing buffered ortho ester polymers | |
| ATE269693T1 (de) | Abführmittel und verfahren zu deren herstellung | |
| NZ521515A (en) | Composition comprising paracetamol and niflumic acid |